Publications Office of the EU
Pre-exposure prophylaxis for HIV prevention in Europe
DisplayCustomHeader
MyPortal
čeština
BasketSummary
Web Content Display (Global)
Publication Detail Actions Portlet

Nástroje

Publication Detail Actions Portlet
 Uživatelské hodnocení
custom-survey-notification
Publication Detail Portlet

Publication detail

Home

Pre-exposure prophylaxis for HIV prevention in Europe

Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia : 2016 progress report

Existuje novější vydání této publikace

Metadata o publikaci

Pre-exposure prophylaxis (PrEP) can reduce the risk of infections in HIVseronegative persons at substantial risk, as long as it is taken as prescribed. - Use of PrEP as an additional prevention option has the potential to reduce HIV transmission and contribute to reversing the increase in new infections in Europe. - France is the only country in Europe currently providing PrEP through public health services, but a number of other countries are implementing or planning to implement PrEP demonstration projects. - Use of antiretroviral medication for PrEP has been approved in the European Union, but countries cite the cost of drugs as a key barrier to provision of PrEP by public health services.
Zobrazit více
Zobrazit méně
ISBN 978-92-9193-995-4
DOI 10.2900/363188
Katalogové číslo TQ-06-16-160-EN-N
ISBN 978-92-9193-994-7
DOI 10.2900/017557
Katalogové číslo TQ-06-16-160-EN-C
PDF
ISSN ISBN 978-92-9193-995-4 DOI 10.2900/363188 Katalogové číslo TQ-06-16-160-EN-N
Tištěná podoba
ISSN ISBN 978-92-9193-994-7 DOI 10.2900/017557 Katalogové číslo TQ-06-16-160-EN-C
  • Released on EU publications website:
Publication Viewer

Prohlížeč dokumentů

Pop up window annotations